The Valley Desk

NCT00088543 · Interventional trial

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant

Overall registry status Completed

Conditions Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Graft vs. Host Disease (GvHD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov